Compare Ascendis Pharma A/S (ASND) vs Duolingo Inc (DUOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Duolingo Inc — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Duolingo Inc trades at $133.25 (market cap $6.34B). The key difference: Ascendis Pharma A/S is far larger — about 2.6× Duolingo Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals.
| ASND | DUOL | |
|---|---|---|
Market Cap | $16.67B | $6.34B |
Sector | Health | Technology |
52-Week High | $277.18 | $369.19 |
52-Week Low | $189.74 | $90.03 |
Enterprise Value | $17.04B | $5.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →
